Exit interview: Stephen Ubl moves on from AdvaMed

Exit interview: Stephen Ubl moves on from AdvaMed
DeviceTalks Podcast Network
Exit interview: Stephen Ubl moves on from AdvaMed

Oct 15 2015 | 00:25:55

/
Episode • October 15, 2015 • 00:25:55

Hosted By

Kayleen Brown Tom Salemi

Show Notes

Before Stephen Ubl departed for a job as the chief lobbyist for the pharmaceutical industry, medtech's main man in Washington D.C. sat down with us to reflect on his time as CEO of AdvaMed. In this episode of DeviceTalks, we go deep into Ubl's background, the fights over the medical device tax, forging a new partnership with the FDA and more.

Previous Episode

Marie Johnson and the mission to prevent sudden heart attacks

Next Episode

Building the Cologuard and the fight against colorectal cancer with Exact Sciences Graham Lidgard

Other Episodes

October 16, 2020

Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work?

In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle. In our opening keynote address sponsored by Medical...

Play

00:45:02

March 11, 2022

Medtronic’s Saba on how equity, inclusion lifts an organization; Tell your MedTech Innovator Story!

In this week’s podcast, we’ll speak with Sally Saba, MD, Medtronic’s chief inclusion and diversity officer, about the company’s work to create a more...

Play

01:21:24

July 09, 2021

Leerink sees surge in home dialysis; Vensana, LRV detail deal in CardioDx start-up Cleerly Health

This week we’ll focus on investor insights. First, we’ll talk with Danielle Antalffy, managing director at SVB Leerink. Antalffy covers most of the major...

Play

01:17:26